Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinoma

Table 2 Baseline characteristics of patients

Clinical pathological characteristic	N	FERMT2		P	FKBP3		P	SMAD9		P	GATA2		P	ITIH4		P
Clinical pathological characteristic	N	Positive	Negative	P	Positive	Negative	P	Positive	Negative	P	Positive	Negative	P	Positive	Negative	P
Age (t/yr)							0.3321			0.5438			0.6755			0.6112
≥ 60	19	17	2	0.4130	17	2		5	14		4	15		4	15
< 60	11	9	2		8	3		3	8		3	8		2	9
Sex							0.5427			0.6472			0.7011			0.4328
Male	17	14	2	0.5052	15	2		4	13		4	13		3	14
Female	13	12	1	0.5052	10	3		2	11		3	10		3	10
Histological differentiation							0.0382			0.0444			0.0311			0.0227
High or middle differentiation	10	9	1	0.0232	8	2		3	7		3	7		5	5
Low or no differentiation	20	17	3		17	3		5	15		4	16		1	19
TNM stage							0.0371			0.0319			0.0215			0.0333
I-II	18	15	3	0.0167	15	3		5	13		3	15		2	16
III-IV	12	11	1	0.0167	10	2		3	9		4	8		4	8
Lymph node metastasis							0.0023			0.0034			0.0076			0.0041
No	14	11	3	0.0054	11	3		6	8		5	9		5	9
Yes	16	15	1	0.0054	14	2		2	14		3	14		1	15

ISSN: 1471-2407